Anything Rare is Possible: Letrozole Induced Eczematous Skin Eruption
Letrozole is used as first line drug in postmenopausal women with early-stage or advanced hormone-sensitive breast cancer. Letrozole has favourable tolerability profile when administered once daily and significant adverse reactions occur rarely. The objective of this report is to describe a case o...
Main Authors: | Amruta Tripathy, Meena Kumari. K, Mohan Babu A.V., Sathish Pai B, Mahesh Kumar D. |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2014-06-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/4498/9028_F(DK)_PF1(P_S)_PFA(AK)_PF2(PAG)_PF2(PN_NC).pdf |
Similar Items
-
Drastic antitumor response following administration of afatinib immediately after atezolizumab in a patient with epidermal growth factor receptor tyrosine kinase inhibitor‐resistant lung cancer
by: Toshiyuki Sumi, et al.
Published: (2021-07-01) -
An eczematous eruption on the arm
by: Kazunari Sugita, et al.
Published: (2021-01-01) -
Gabapentin-Induced Choreoathetosis
by: J Gordon Millichap
Published: (1997-09-01) -
PEGylated Liposomal Doxorubicin Rechallenge following Doxorubicin-induced Pancreatitis
by: Luke Ardolino, et al.
Published: (2020-12-01) -
Successful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue
by: Yasuyuki Asada, et al.
Published: (2021-07-01)